Member Info for Dalester

I thought that the Chairman appointment would be indicative of the direction of future travel, thankfully they have gone for a top business leader, a deal-maker, capable of generating the excitement in the industry for Scancell's products that long- term holders here have always believed were possible. Clearly he knows what we have and is excited, scancell have tweeted this morning that they are excited at his arrival. Excited is the word of the day!

As one of the critics of the commercial side of the business, I warmly welcome this appointment, clearly our new Chairman has the contacts, experience and commercial nous we so urgently needed. Well done to everyone involved in this appointment. It would seem we have caught a whale, a genuine rainmaker who can drive the company to the commercial success its products deserve. Now I am really excited!

Ruck, there is no need to be rude. I have had a colourful and fascinating career. I was challenged to prove what I know about sales and the only " proof" as such is my long and eventful CV littered with great companies and great deals. If you choose to belittle my expertise I guess thats up to you but it makes you a lesser person than I imagined . It is a cheap shot and and unwarranted. I' m sorry you don't value an opinion that differs from the hymn sheet. Lets see who they appoint as the new Chair eh?

Hi Krafty, I have been a salesman most of my working life, I have sold German text books to Ghadaffi, spent time in N. Cyprus dealing with Asil Nadir, I was the first UK salesman to get UK software licenced and translated into Mandarin in China ( at Fudan University), i did multi-million dollar licencing deals with Virgin Interactive, Corel , Interactive Arts and many more in the US. Initially worked for Procter and Gamble and then the Thomson Corporation as UK sales manager for one of their publishing houses before going into international sales in the Software and video games industry.
I think I know a little bit about sales and salesmen. Put simply , great products deserve great deals, underselling is easy, any one can do it.

Cleaner, bearing all that in mind, its a shame we only got £6m upfront from Genmab. It seems like a failure of salesmanship. One of the biggest failings of UK business is to understand the value of what they are selling and an inability on the part of people doing the selling to ask for proper value for their products. Goodfellow was mates with the Genmab crowd, did he do us a favour or did he do them a favour? What number did he put on the table as a starting point ? £600m looks like a decent deal, but its 99% jam tomorrow.I bet he asked for £10m and accepted £6m but where would he have ended up if he had asked ror £100m? Genmab obviously did their due diligence and liked what they saw or there would be no deal at all.
I just wish we had a salesman or woman in the business, my fingers are crossed they find a dealmaker as the new Chairman or woman, someone who knows the value of what he is selling and has the minerals to ask for a big number.

Tweet
See new Tweets
Conversation
Scancell
@scancellpharma
We are pleased to have been awarded a Singaporean patent on our anti-glycan monoclonal antibody with specificity for the sialyl-di-Lewis? glycan expressed on glycoprotein

Chester, it feels as though they are clearing the decks....get the interims out of the way and then have a clear runway for other ( good) news. Better than making a big announcement and then having the interims and then trying to get back to the good news I would have thought, especially if the good news makes the interims somewhat redundant.

I am reminded that when we were all excited about the SCIB1 trial results, many said that there were not enough people in the trial to warrant any big offers being made. Clearly there are more in the MODI 1 trial, but I wonder if Lindy has SCIB1 in the back of mind and is waiting for a ton of irrefutable data prior to writing the killer RNS. They know it seems to be working, we know its working for at least one person, at some point we hope Lindy will be able to "blow the bloody doors off" but to do that, she has to collect lots of data and the numbers involved will need to be enough to prevent the naysayers from talking it down. Meanwhile we wait.... Tick Tock

Just found the FDA approved list of Mabs with companies that own them
https://en.wikipedia.org/wiki/Monoclonal_antibody_therapy

Konar, thanks , I kind of figured that the Mab bit was indicative, I was being lazy! I found a wiki entry on mabs and it would seem there arr over 500 of them listed! I have no idea how many are actually in use but its a lot more than I imagined. And if they can benefit from Avidimab ... multi multi multi millions!
https://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies

Konar...."but there are plenty of companies out there that will happily mass produce generic versions of off patent medication and undercut the market."
Have I misunderstood this, or does this infer that Scancell or a company licencing avidimab, could take lots of existing, out of patent, medicines and add avidimab to them to create a new patented, and more effective version of the current product? This would be potentially a huge licencing opportunity, does anyone have any idea how many drugs are out there that could benefit?

From wiki
In December 2022, Merck announced a licensing deal with Kelun-Biotech of China whereby it would expand it's early cancer pipeline with a set of antibody-drug conjugates; this follows an earlier agreement between the two companies to co-develop such drugs

“I can’t really believe that result yet;... It has completely blown my socks off that the vaccine should be working so well, so early in the process. Once we get more results from other parts of the trial we will issue an absolutely stonking RNS"

“I can’t really believe that result yet;... It has completely blown my socks off that the vaccine should be working so well, so early in the process. Once we get more results from other parts of the trial we will issue an absolutely stonking RNS"

I think HMG may be keen to be seen to be doing "something" to mitigate the disaster of 2 years of the NHS being practically closed to 1000s of new cancer patients. The new BioNtech collaboration is not expected to bear fruit until 2030 so imagine their excitement if Lindy has pulled their tripes out of the mincer! They will be all over us like a rash.

Have Pfizer and BioNtech sorted out the Moderna lawsuit over the mRNA technology yet?
I'm not sure the UK Government should be getting involved whilst the IP is subject to a legal case
https://www.fiercepharma.com/pharma/clash-titans-moderna-sues-pfizer-and-biontech-patent-infringement

Google Finance showing it as a 400k buy...?

Following on from the National Geographic....I have had my guerilla marketing hat on and found a list of UK scientific journalists the other day, I am contemplating linking the Modi RNS to an email when it arrives, and sending it to those who are interested in biotech stories, always assuming it says what we think it might.
I am sure there must be journals, etc. in other countries that interested shareholders might want to make a note of too. Maybe some ot the more scientifically minded amongst us might prepare a "laymans translation " so that just about anyone might be able to understand the basic implications?
I imagine official press releases will hit the outlets that SCLP deem to be key, but there are thousands of places it won't touch, but a concerted effort by SHs might . Thoughts?

I think I would now prefer to wait until January for news. I think we have had a taster from the patient and the Prof's cancer vaccines comment, better now to hit the market with a massive RNS in January and then give the News and Media at large time to digest and recognise the magnitude of what we think is happening. Releasing news now will make it difficult for news channels to make as much of the news as it deserves, they will be able to give it their full attention in January, people will be back off holidays and available for interviews, the press and TV will be gagging for good news stories. All in all, I think it just makes better sense, we have had a little Santa Rally, lets enjoy Christmas and New Year and then we will all be ready for the medical earthquake.... As ever, fingers crossed....

I reckon he found a very cute way to send a signal to those who know without crossing any boundaries, certainly his comments will not mean anything to those who are not in the know. He is clearly delighted that there is hope for his patients after all the years of long drawn out defeats and disappointments. What did the Mm person say? A real buzz around the place? I think we know why ....